This content is machine translated Ischemic stroke: Are smaller or larger brain arteries affected? Recent study findings on intravenous lysis therapy with fibrinolytic agents Intravenous thrombolysis, with or without mechanical thrombectomy, is a key pillar in the treatment of ischemic stroke. There are now two approved treatment options available—alteplase and tenecteplase—and Phase II data...…
View Post 5 min This content is machine translated Acute ischemic stroke Alteplase and Tenecteplase Are on the Same Level In acute ischemic stroke (AIS), rapid reperfusion therapy is a clinical priority. Although alteplase has been the standard thrombolytic agent for many years, its short half-life requires administration as a...…
View Post 3 min This content is machine translated Intravenous thrombolysis Ischemic stroke: dose of intravenous alteplase. Purpose: Previously published results of the ENCHANTED (Enhanced Control of Hypertension and Thrombolysis) trial indicate whether low-dose intravenous alteplase (0.6 mg/kg/KG; standard dose 0.9 mg/kg/KG) improves the outcome of patients with ischemic…
